REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$357.22
*  
2.70
0.75%
Get REGN Alerts
*Delayed - data as of Sep. 23, 2014  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Earnings Up at Jazz Pharma, Guidance Reiterated - Analyst Blog
5/9/2014 9:40:00 AM - Zacks.com

Regeneron Beats on Earnings, Revenues in Q1 - Analyst Blog
5/8/2014 1:27:00 PM - Zacks.com

Will Regeneron (REGN) Disappoint in Q1 Earnings? - Analyst Blog
5/7/2014 5:20:01 PM - Zacks.com

Pre-Market Earnings Report for May 8, 2014 : PCLN, VRX, PCP, APA, REGN, MGA, MPEL, HCN, ICE, DISH, LMCA, LINTA
5/7/2014 4:00:01 PM - NASDAQ.com News

Regeneron Inks Ophthalmology Deal - Analyst Blog
5/6/2014 5:20:01 PM - Zacks.com

Cramer's Mad Money - 15 Earnings To Watch In The Week Ahead (5/2/14)
5/4/2014 6:12:00 AM - Seeking Alpha

Amicus Up on Positive Data - Analyst Blog
4/30/2014 2:32:01 PM - Zacks.com

Sanofi Misses on Q1 Earnings, Lackluster Revs - Analyst Blog
4/30/2014 11:07:01 AM - Zacks.com

Amicus Therapeutics (FOLD) Jumps: Stock Up 20.7% - Tale of the Tape
4/30/2014 9:39:01 AM - Zacks.com

GTX Inc. (GTXI) Jumps: Stock Up 14.4% - Tale of the Tape
4/30/2014 8:51:01 AM - Zacks.com

Hyperion Set to Acquire Andromeda - Analyst Blog
4/29/2014 5:58:01 PM - Zacks.com

Regeneron Pharmaceuticals (REGN) Shares Cross Above 200 DMA
4/29/2014 11:39:23 AM - BNK Invest

Amazon.com: The Most Overvalued Profitable Company In The S&P 500, Still
4/29/2014 5:33:00 AM - Seeking Alpha

If You Want GARP, Look Into Biotech, Not Utilities, But Do The Valuations
4/28/2014 11:35:00 AM - Seeking Alpha

Progenics Finishes Patient Enrollment - Analyst Blog
4/25/2014 7:00:01 PM - Zacks.com

Johnson & Johnson Boosts Dividend 6.1% - Analyst Blog
4/25/2014 6:00:01 PM - Zacks.com

Wider-than-Expected Q1 Loss at AMAG - Analyst Blog
4/25/2014 11:00:01 AM - Zacks.com

Emergent's BioThrax Gets Orphan Drug Status - Analyst Blog
4/24/2014 7:10:01 PM - Zacks.com

Alexion Posts Strong Earnings in Q1 - Analyst Blog
4/24/2014 5:00:01 PM - Zacks.com

Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog
4/24/2014 1:27:01 PM - Zacks.com

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
4/23/2014 5:30:01 PM - Zacks.com

Biogen's Q1 Earnings Soar Y/Y on Tecfidera Sales - Analyst Blog
4/23/2014 1:40:01 PM - Zacks.com

Strong Q1 Earnings at Gilead on Stellar Sovaldi Sales - Analyst Blog
4/23/2014 12:00:01 PM - Zacks.com

Cubist Pharma Posts Weak Earnings on Soft Cubicin Sales - Analyst Blog
4/23/2014 11:30:01 AM - Zacks.com

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
4/22/2014 4:45:01 PM - Zacks.com